Key result
Patients with peripheral arterial disease exhibited a significantly greater increase in renal vascular resistance during the first minute of exercise compared to controls (26% vs 3%; P<0.05).
Why the study?
Do patients with peripheral arterial disease have augmented renal vasoconstriction during exercise, and does oxidative stress contribute to this response?
Case-Control (n=21)
Do patients with peripheral arterial disease have augmented renal vasoconstriction during exercise, and does oxidative stress contribute to this response?
Absolute Event Rate: 26% vs 3%
p-value: p=<0.05
Patients with peripheral arterial disease exhibit exaggerated renal vasoconstriction during exercise, a response that appears to be partially mediated by oxidative stress.
Exaggerated renal vasoconstriction during early exercise in PAD may signal heightened cardiorenal strain; this Level 4 finding leaves open mechanisms and interventional targets.
Peripheral arterial disease (PAD) patients have augmented blood pressure increases during exercise, heightening their cardiovascular risk. However, it is unknown whether patients have exaggerated renal vasoconstriction during exercise and if oxidative stress contributes to this response. Eleven PAD patients and 10 controls (CON) performed 4-min mild, rhythmic, plantar flexion exercise of increasing intensity (0.5-2 kg) with each leg (most and least affected in PAD). Eight patients also exercised with their most affected leg during ascorbic acid (AA) infusion. Renal blood flow velocity (RBFV; Doppler ultrasound), mean arterial blood pressure (MAP; Finometer), and heart rate (HR; electrocardiogram [ECG]) were measured. Renal vascular resistance (RVR), an index of renal vasoconstriction, was calculated as MAP/RBFV. Baseline RVR and MAP were similar while HR was higher in PAD than CON (2.08 ± 0.23 vs. 1.87 ± 0.20 au, 94 ± 3 vs. 93 ± 3 mmHg, and 72 ± 3 vs. 59 ± 3 bpm [P < 0.05] for PAD and CON, respectively). PAD had greater RVR increases during exercise than CON, specifically during the first minute (PAD most: 26 ± 5% and PAD least: 17 ± 5% vs. CON: 3 ± 3%; P < 0.05). AA did not alter baseline RVR, MAP, or HR. AA attenuated the augmented RVR increase in PAD during the first minute of exercise (PAD most: 33 ± 4% vs. PAD most with AA: 21 ± 4%; P < 0.05). In conclusion, these findings suggest that PAD patients have augmented renal vasoconstriction during exercise, with oxidative stress contributing to this response.
No takes yet. Share an insight, caveat, or question.
Drew et al. (2013) conducted a case-control in Peripheral arterial disease (n=21). Peripheral arterial disease vs. Healthy controls was evaluated on Increase in renal vascular resistance (RVR) during the first minute of exercise (p=<0.05). Patients with peripheral arterial disease exhibited a significantly greater increase in renal vascular resistance during the first minute of exercise compared to controls (26% vs 3%; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: